PDGFRA and cancer: Despite the distinct adaptive RTK response in mouse vs. human lapatinib-resistant cancer cells, notably, they share an important common feature, i.e., stabilized PDGFRα, PDGFRβ, and MET that are maintained by Hsp90 (https://www.picard.ch/downloads/Hsp90interactors.pdf).